Report cover image

Rosacea Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

Publisher GlobalData
Published Jun 06, 2022
Length 62 Pages
SKU # GBDT17311312

Description

Rosacea Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

Summary

This reports provides a data-driven overview of the current and future competitive landscape in Rosacea therapeutics.

Synopsis
  • In 2022, there will be more than 47 million diagnosed prevalent cases of rosacea across 16 pharmaceutical markets.
  • There are 10 FDA approved branded marketed drugs for the treatment of rosacea.
  • The rosacea pipeline consists of over 32 pharmaceuticals spanning all stages of development, with approximately 50% of drugs in early-stage development.
  • Commercial sponsors dominate clinical trial development in rosacea, with the US emerging as the key countries for conducting trials in rosacea.
  • Deals involving acquisition of rosacea assets were the most common type of deals globally.
  • Only three players are developing products for the treatment of rosacea in the late-stage suggesting very limited change in the market scenario in immediate future.
Scope

GlobalData’s Rosacea: Competitive Landscape in 2022 combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

Components of the report include -
  • Disease Landscape
  • Disease Overview
  • Epidemiology Overview
  • Treatment Overview
  • Marketed Products Assessment
  • Breakdown by Mechanism of Action, Molecule Type and Route of Administration
  • Pipeline Assessment
  • Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
  • Late-to-mid-stage Pipeline Drugs
  • Phase Transition Success Rate and Likelihood of Approval
  • Clinical Trials Assessment
  • Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
  • Enrolment Analytics, Site Analytics, Feasibility Analysis
  • Deals Landscape
  • Mergers, Acquisitions, and Strategic Alliances by Region
  • Overview of Recent Deals
  • Commercial Assessment
  • Key Market Players
  • Future Market Catalysts
Reasons to Buy
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the Rosacea market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Rosacea market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Table of Contents

62 Pages
  • Key Findings
    • Disease Overview
    • Epidemiology Overview: Diagnosed Prevalent Cases of Rosacea in 2022 and 2027
    • Treatment Guidelines
    • Marketed Drugs Overview
    • Marketed Drugs - Overview by Mechanism of Action
    • Marketed Drugs - Overview by Route of Administration
    • Pipeline Drugs Overview - Phase III and Phase II Pipeline Drugs in Rosacea
    • Pipeline Drugs - Overview by Development Stage
    • Pipeline Drugs - Overview by Molecule Type
    • Pipeline Drugs - Overview by Mechanism of Action
    • Pipeline Drugs - Overview by Route of Administration
    • Pipeline Drugs - PTSRs and LoAs in Dermatology and Rosacea
    • Pipeline Drugs - Drug-Specific Phase Transition Success Rates and Likelihood of Approval in Rosacea
    • Clinical Trials in Rosacea - Historical Overview
    • Clinical Trials in Rosacea - Overview by Phase
    • Clinical Trials in Rosacea - Overview by Status
    • Clinical Trials in Rosacea - Overview by Phase for Ongoing and Planned Trials
    • Clinical Trials in Rosacea - Trials with a Virtual Component
    • Clinical Trials in Rosacea - Geographic Overview
    • Clinical Trials in Rosacea - Single-Country and Multinational Trials by Region
    • Clinical Trials in Rosacea - Top 20 Sponsors with Breakdown by Phase
    • Clinical Trials in Rosacea - Top 20 Sponsors with Breakdown by Status
    • Clinical Trials in Rosacea - Overview by Endpoint Status
    • Clinical Trials in Rosacea - Overview by Race and Ethnicity
    • Clinical Trials in Rosacea - Enrollment Data
    • Clinical Trials in Rosacea - Overview of Sites by Geography
    • Clinical Trials in Rosacea - Top 20 Countries for Trial Sites
    • Clinical Trials in Rosacea - Top 20 Sites Globally
    • Clinical Trials - Feasibility Analysis: Geography Overview
    • Clinical Trials - Feasibility Analysis: Benchmark Models for Rosacea
    • Deals Landscape - Mergers, Acquisitions, and Strategic Alliances in Rosacea by Region
    • Deals Landscape - Recent Mergers, Acquisitions, and Strategic Alliances in Rosacea
    • Commercial Assessment - Key Market Players in Rosacea
    • Future Market Catalysts - Upcoming Market Catalysts in Rosacea
    • Methodology
    • Methodology - Sales Forecasts
    • Methodology - Phase Transition Success Rate and Likelihood of Approval Analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us